TY  - GEN
AU  - Devine,Steven M
AU  - Owzar,Kouros
AU  - Blum,William
AU  - Mulkey,Flora
AU  - Stone,Richard M
AU  - Hsu,Jack W
AU  - Champlin,Richard E
AU  - Chen,Yi-Bin
AU  - Vij,Ravi
AU  - Slack,James
AU  - Soiffer,Robert J
AU  - Larson,Richard A
AU  - Shea,Thomas C
AU  - Hars,Vera
AU  - Sibley,Alexander B
AU  - Giralt,Sergio
AU  - Carter,Shelly
AU  - Horowitz,Mary M
AU  - Linker,Charles
AU  - Alyea,Edwin P
TI  - Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502
SN  - 1527-7755
PY  - 2016///0404
KW  - Aged
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - administration & dosage
KW  - Busulfan
KW  - Disease-Free Survival
KW  - Drug Administration Schedule
KW  - Female
KW  - Graft vs Host Disease
KW  - diagnosis
KW  - Hematopoietic Stem Cell Transplantation
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Leukemia, Myeloid, Acute
KW  - drug therapy
KW  - Male
KW  - Methotrexate
KW  - Middle Aged
KW  - Neoplasm Recurrence, Local
KW  - Prospective Studies
KW  - Remission Induction
KW  - Tacrolimus
KW  - Transplantation Conditioning
KW  - methods
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Unrelated Donors
KW  - Vidarabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1200/JCO.2015.62.7273
ER  -